CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Us-china Biomedical Technology, Inc.  (CLDS)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

CLDS's Net Income Growth by Quarter and Year

Us-china Biomedical Technology,'s Net Income results by quarter and year




CLDS Net Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter February - -0.08 0.01 1.20
III Quarter November - -0.13 -0.01 -0.01
II Quarter August -0.14 -0.23 -0.02 -0.02
I Quarter May -0.27 -0.04 -0.02 -0.02
FY   -0.41 -0.48 -0.04 1.15



CLDS Net Income second quarter 2019 Y/Y Growth Comment
Us-china Biomedical Technology, Inc. in the second quarter recorded net loss of $ -0.14 millions.

According to the results reported in the second quarter, Us-china Biomedical Technology, Inc. achieved the best Net Income growth in Healthcare Facilities industry. While Us-china Biomedical Technology, Inc.' s Net Income no change of % ranks overall at the positon no. in the second quarter.




CLDS Net Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter February - - -99.17 % 900 %
III Quarter November - - - -
II Quarter August - - - -
I Quarter May - - - -
FY   - - - -

Financial Statements
Us-china Biomedical Technology,'s second quarter 2019 Net Income $ 0.00 millions CLDS's Income Statement
Us-china Biomedical Technology,'s second quarter 2018 Net Income $ 0.00 millions Quarterly CLDS's Income Statement
New: More CLDS's historic Net Income Growth >>


CLDS Net Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter February - - - -
III Quarter November - - - -
II Quarter August - - - -
I Quarter May - - - -
FY (Year on Year)   - - - -




Net Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Us-china Biomedical Technology,'s Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CLDS's II. Quarter Q/Q Net Income Comment
Even if Us-china Biomedical Technology, Inc. in the II. Quarter 2019 showed net loss of $ -0.14 millions, management mentioned, that those numbers show improvement relative to the -0.27 millions in the first quarter.

Within Healthcare Facilities industry Us-china Biomedical Technology, Inc. achieved highest sequential Net Income growth. While Us-china Biomedical Technology,'s Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CLDS's II. Quarter Q/Q Net Income Comment
Even if Us-china Biomedical Technology, Inc. in the II. Quarter 2019 revealed net loss of $ -0.14 millions, management point out, that current results show recovery compare to the -0.27 millions in the first quarter.

Within Healthcare Facilities industry Us-china Biomedical Technology, Inc. achieved highest sequential Net Income growth. While Us-china Biomedical Technology,'s Net Income growth quarter on quarter, overall rank is .


Us-china Biomedical Technology,'s 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Aug 31 2018)
12 Months Ending
(May 31 2018)
12 Months Ending
(Feb 28 2018)
12 Months Ending
(Nov 30 2017)
12 Months Ending
(Aug 31 2017)
Cumulative Net Income 12 Months Ending $ -0.62 $ -0.72 $ -0.48 $ -0.40 $ -0.28
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Us-china Biomedical Technology, Inc.' has realized cumulative trailing twelve months net loss of $ -1 millions in the Aug 31 2018 period.

Us-china Biomedical Technology, Inc. achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Us-china Biomedical Technology, Inc.' has realized cumulative trailing twelve months net loss of $ -1 millions in the Aug 31 2018 period.

Us-china Biomedical Technology, Inc. achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


You need to upgrade your Flash Player




Other Net Income Growth
Healthcare Facilities Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
CLDS's Net Income Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for CLDS's Competitors
Net Income Growth for Us-china Biomedical Technology,'s Suppliers
Net Income Growth for CLDS's Customers

You may also want to know
CLDS's Annual Growth Rates CLDS's Profitability Ratios CLDS's Asset Turnover Ratio CLDS's Dividend Growth
CLDS's Roe CLDS's Valuation Ratios CLDS's Financial Strength Ratios CLDS's Dividend Payout Ratio
CLDS's Roa CLDS's Inventory Turnover Ratio CLDS's Growth Rates CLDS's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Aug 31 2018 within Healthcare SectorY/Y Change %Net Income for the quarter ending Aug 31 2018
Cryo Cell International Inc -62.43 %$ -62.427 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RESN's Profile

Stock Price

RESN's Financials

Business Description

Fundamentals

Charts & Quotes

RESN's News

Suppliers

RESN's Competitors

Customers & Markets

Economic Indicators

RESN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071